Monitoring Agency Report for Quarter Ended 30th September, 2025
Stallion India Fluorochemicals Limited's monitoring agency report for the quarter ended September 30, 2025, identifies deviations in IPO proceeds utilization, including excess spending on issue expenses and commingling of funds.
The deviations in the use of IPO funds and the commingling of funds could potentially affect investor confidence and the company's financial planning.
The report indicates deviations from the planned use of IPO funds, including overspending on issue expenses, which raises concerns about financial management.
* CARE Ratings Limited submitted a Monitoring Agency Report for Stallion India Fluorochemicals Limited for the quarter ended September 30, 2025, regarding the utilization of IPO proceeds. * The report identifies deviations, including excess utilization of ₹3.99 crore towards issue expenses, where actual spending was ₹15.98 crore against the ₹11.99 crore specified in the prospectus. * The report also notes that the utilization of proceeds was routed through multiple current accounts, resulting in the commingling of funds. * The total excess utilization in certain objects is ₹7.70 crore, potentially leading to a deficit in available IPO proceeds for other specified objects. * As of September 30, 2025, the total unutilized amount from the IPO proceeds is ₹30.81 crore, invested in various fixed deposits and bank accounts.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.